July 25, 2020
2 min watch
Save
VIDEO: Uveitis recurrence rate lower with Yutiq implant than in clinical trials
In this video from the virtual American Society of Retina Specialists meeting, Dilraj Grewal, MD, MBBS, discusses a study evaluating the recurrence of uveitis after treatment with the Yutiq insert from EyePoint Pharmaceuticals.
The study found that the rate of recurrence of noninfectious posterior segment uveitis was lower than that found in the clinical trials of the fluocinolone acetonide intravitreal implant.